NCT06441331 · Interventional trial
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Overall registry status Recruiting
Phase 1
Conditions CNS Tumors, GIST, Lymphoma, NETs, Peripheral Primitive Neuroectodermal Tumor, Rhabdomyosarcoma, Solid Tumor, Somatostatin Receptor Positive
Delaware Valley sites
- The Children's Hospital of Philadelphia (CHOP) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory